Loading...
Loading...
Hyperion
Therapeutics, Inc.
HPTX announced today the completion of its
follow-on offering of 2,875,000 shares of common stock. In addition, the
underwriters exercised their over-allotment option in full and purchased an
additional 431,250 shares of common stock. All such shares were sold by
Hyperion at the follow-on offering price of $20.75 per share. The net proceeds
to Hyperion from this offering are approximately $64.5 million, after
deducting underwriter discounts and commissions. Leerink Swann LLC and Cowen
and Company, LLC acted as joint book-running managers for the offering, and
Needham & Company, LLC and JMP Securities LLC acted as co-managers for the
offering.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in